en
Feedback
Drug & Poison Information Channel

Drug & Poison Information Channel

Open in Telegram

It provides up to date, evidenced based, concised drug information to all health care professionals. Supervised by: Ph. Amal Al-Najjar. To communicate,participate and questions: @Amal_alNajjar.

Show more
The country is not specifiedMedicine10 169
1 957
Subscribers
-124 hours
-67 days
-1230 days

Data loading in progress...

Similar Channels
التعليم الصيدلاني الإلكتروني المستمر
5.2K
التعليم الصيدلاني الإلكتروني المستمر
Internal Medicine
5.0K
Internal Medicine
صفحة من كتاب 📄
4.1K
صفحة من كتاب 📄
Basic & Clinic 4 students
2.2K
Basic & Clinic 4 students
أبو محمد المالكي
2.1K
أبو محمد المالكي
avatar
1
More channels
Tags Cloud
No data
Any problems? Please refresh the page or contact our support manager.
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
July '26
July '26
+1
in 0 channels
June '26
+3
in 0 channels
Get PRO
May '26
+4
in 0 channels
Get PRO
April '26
+4
in 0 channels
Get PRO
March '260
in 0 channels
Get PRO
February '26
+3
in 0 channels
Get PRO
January '26
+6
in 0 channels
Get PRO
December '25
+2
in 0 channels
Get PRO
November '25
+3
in 0 channels
Get PRO
October '25
+6
in 0 channels
Get PRO
September '25
+3
in 0 channels
Get PRO
August '25
+4
in 0 channels
Get PRO
July '25
+5
in 0 channels
Get PRO
June '25
+7
in 0 channels
Get PRO
May '25
+5
in 0 channels
Get PRO
April '250
in 0 channels
Get PRO
March '25
+2
in 0 channels
Get PRO
February '25
+5
in 0 channels
Get PRO
January '25
+8
in 0 channels
Get PRO
December '24
+5
in 0 channels
Get PRO
November '24
+2
in 0 channels
Get PRO
October '24
+2
in 0 channels
Get PRO
September '24
+11
in 0 channels
Get PRO
August '24
+18
in 0 channels
Get PRO
July '24
+4
in 0 channels
Get PRO
June '24
+1
in 0 channels
Get PRO
May '24
+9
in 0 channels
Get PRO
April '24
+8
in 0 channels
Get PRO
March '24
+6
in 0 channels
Get PRO
February '24
+8
in 0 channels
Get PRO
January '24
+15
in 1 channels
Get PRO
December '23
+8
in 0 channels
Get PRO
November '23
+4
in 0 channels
Get PRO
October '23
+7
in 0 channels
Get PRO
September '23
+10
in 0 channels
Get PRO
August '23
+5
in 0 channels
Get PRO
July '23
+6
in 0 channels
Get PRO
June '23
+13
in 0 channels
Get PRO
May '23
+20
in 0 channels
Get PRO
April '23
+8
in 0 channels
Get PRO
March '23
+8
in 0 channels
Get PRO
February '23
+7
in 0 channels
Get PRO
January '23
+18
in 0 channels
Get PRO
December '22
+16
in 0 channels
Get PRO
November '22
+52
in 0 channels
Get PRO
October '22
+24
in 0 channels
Get PRO
September '22
+20
in 0 channels
Get PRO
August '22
+12
in 0 channels
Get PRO
July '22
+13
in 0 channels
Get PRO
June '22
+16
in 0 channels
Get PRO
May '22
+61
in 0 channels
Get PRO
April '22
+26
in 0 channels
Get PRO
March '22
+14
in 0 channels
Get PRO
February '22
+27
in 0 channels
Get PRO
January '22
+14
in 0 channels
Get PRO
December '21
+16
in 0 channels
Get PRO
November '21
+17
in 0 channels
Get PRO
October '21
+25
in 0 channels
Get PRO
September '21
+31
in 0 channels
Get PRO
August '21
+19
in 0 channels
Get PRO
July '21
+25
in 0 channels
Get PRO
June '21
+65
in 0 channels
Get PRO
May '21
+14
in 0 channels
Get PRO
April '21
+21
in 0 channels
Get PRO
March '21
+44
in 0 channels
Get PRO
February '21
+30
in 0 channels
Get PRO
January '21
+41
in 0 channels
Get PRO
December '20
+2 219
in 0 channels
Date
Subscriber Growth
Mentions
Channels
06 July0
05 July0
04 July+1
03 July0
02 July0
01 July0
Channel Posts
Drug & Poison Information Channel
image_2026-07-03_23-43-01.png4.69 KB

2
image_2026-07-03_23-42-50.png
56
3
https://pubmed.ncbi.nlm.nih.gov/42313397/
129
4
🚦Regulatory Alert: EMA & FDA Move to Revoke Avacopan (Tavneos) Medicine: Tavneos (avacopan) Class: Oral complement C5a-receptor antagonist Indication: Severe, active Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) in adults, alongside standard therapy. The Update The European Medicines Agency’s (EMA) committee has recommended revoking the EU marketing authorization for Avacopan, concluding its benefits no longer outweigh its risks. The US FDA is concurrently moving to withdraw the drug on the exact same grounds. The Reason: Data Integrity, Not Safety This transatlantic withdrawal is not triggered by a new adverse event, but by severe data integrity issues regarding the pivotal ADVOCATE trial (n=331) that originally supported its approval: Evidence revealed that trial results were manipulated by unblinded personnel to make the drug appear effective. The original data analysis did not support the conclusion of efficacy. This original, unfavorable analysis was actively hidden from regulatory agencies during the initial approval process in 2021/2022. (EMA CHMP Article 20 Assessment Report (June 2026) & FDA Federal Register Proposal Notice (April 30, 2026)).
148
5
كيف نفهم أرقام الـ (Hazard Ratio) بشكل عام؟ إذا كان الـ HR يساوي 1: العلاجان متطابقان تماماً، ولا يوجد أي فرق في الخطورة بين المجموعتين. إذا كان الـ HR أقل من 1 (مثل 0.58): العلاج الجديد أفضل، لأنه يقلل من احتمالية حدوث الشيء السيء (تفاقم المرض) ويطيل فترة استقرار المريض. إذا كان الـ HR أكبر من 1 (مثلاً 1.5): العلاج الجديد أسوأ، لأنه يزيد من خطر تفاقم المرض بنسبة 50%.
181
6
*Dear Doctor,* I would highly appreciate your participation in our research study titled: *“Effectiveness and Diagnostic Reliability of Tele-dermatology in Primary Care among Family Physicians in Riyadh, Saudi Arabia.”* The survey takes approximately 3 minutes to complete and aims to assess Family physicians’ experiences with virtual dermatology consultations. Participation is voluntary, and all responses are anonymous and confidential. *survey link:* https://forms.gle/PJVigwYeqcdas1Bx6 *Thank you for your valuable time and contribution.*
216
7
https://share.google/DDVcRiNiYAfzsMjy7
0
8
No text...
0
View all posts